Results 1 to 10 of about 1,820,008 (272)

Novel RAD50 variants lead to Nijmegen Breakage Syndrome–like disorder and unplanned recombinant human growth hormone treatment response [PDF]

Frontiers in Endocrinology
BackgroundHuman RAD50 gene mutations cause Nijmegen Breakage Syndrome-like disease, characterized by severe prenatal and postpartum growth retardation and microcephaly.
Yan Gong, MingYu Jiang, ShengNan Wu, Sheng Guo, YongFen Lyu   +4 more
doaj   +2 more sources

Nutritional Counseling in Children with Growth Hormone Deficiency Treated with Recombinant Human Growth Hormone: Analysis of Growth Response Parameters [PDF]

Biomedicines
Background and Objectives: Growth failure is the main symptom of growth hormone deficiency (GHD) in children. The standard treatment for GHD is the administration of recombinant human growth hormone (rhGH).
Joanna Budzulak, Katarzyna Anna Majewska, Andrzej Kędzia   +2 more
doaj   +2 more sources

Polyacrylamide gels with selective recognition of the tetrameric molecular form of human growth hormone

eXPRESS Polymer Letters, 2017
Networks of polyacrylamide were studied for the possibility of imprinting of the oligomeric form of human growth hormone. The tetrameric molecular form of human growth hormone was molecularly imprinted for the first time.
R. Kublickas, C. Werner, B. Voit
doaj   +2 more sources

Recombinant human growth hormone (rHGH) for muscle enhancement in knee osteoarthritis: protocol for a pilot, randomised placebo-controlled trial. [PDF]

BMJ Open
Shah A, Ravi B, Tomescu S, Catapano M, Burkhart TA, Whyne C, Kiss A, Marks P, Wasserstein DN.   +8 more
europepmc   +3 more sources

SAT-039 clinical and demographic characteristics of a cohort of adults IN TREATMENT WITH a biosimilar HUMAN GROWTH HORMONE [PDF]

J Endocr Soc
Alfonso Soto, andres Jimenez sanchez, María Elena Dios Fuentes, Pablo Remón-Ruiz, Eva Venegas Moreno   +4 more
europepmc   +3 more sources

Human growth hormone

The Turkish Journal of Pediatrics, 1966
Z Laron
doaj   +2 more sources

Comparison of the effectiveness of recombinant human growth hormone therapy in preterm and full-term children with short stature born small for gestational age. [PDF]

Ann Pediatr Endocrinol Metab
Kim D, Yoon JH, Hwang S, Kim JH, Yoo HW, Choi JH.   +5 more
europepmc   +3 more sources

Déficit de hormona de crecimiento: influencia de la pubertad en la respuesta al tratamiento

Anales de Pediatría, 2022
Resumen: Introducción: La talla baja es motivo de consulta frecuente en Endocrinología Pediátrica, precisando en ocasiones tratamiento con hormona del crecimiento (GH).
María José Sánchez Malo, Juan Hidalgo Sanz, Cristina Hernández Tejedor, María García Ventura, Marta Ferrer Lozano, Jose Ignacio Labarta Aizpún, Antonio de Arriba Muñoz   +6 more
doaj   +1 more source

Vitamin D and Parathyroid Hormone during Growth Hormone Treatment

Children, 2022
Background. There is some controversy concerning a potential interaction between vitamin D and PTH and the GH/IGF-1 axis. The goal of this study is to assess vitamin D and PTH status in children with GH deficiency at diagnostic and during treatment with ...
Teodoro Durá-Travé, Fidel Gallinas-Victoriano   +1 more
doaj   +1 more source

Laron syndrome: An experience of treatment of two cases

Journal of Clinical and Translational Endocrinology Case Reports, 2021
Laron syndrome or growth hormone insensitivity is a rare disease presenting with severe postnatal growth failure. Clinically, in most circumstances, it is indistinguishable from growth hormone deficiency.
Hiya Boro, Sk Hammadur Rahman, Saurav Khatiwada, Sarah Alam, Rajesh Khadgawat   +4 more
doaj   +1 more source